{"id":"https://openalex.org/W165383261","doi":null,"title":"Alternatives in the treatment of memory loss in patients with Alzheimer's disease.","display_name":"Alternatives in the treatment of memory loss in patients with Alzheimer's disease.","alternate_titles":[],"publication_year":1991,"publication_date":"1991-06-01","ids":{"openalex":"https://openalex.org/W165383261","mag":"165383261","pmid":"https://pubmed.ncbi.nlm.nih.gov/2065522"},"language":"en","primary_location":{"id":"pmid:2065522","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2065522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W165383261"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048819113","display_name":"Burgunda W. Volger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"B W Volger","raw_affiliation_strings":["Drug Information and Investigational Drug Services, University of Michigan Hospitals, Ann Arbor 48109-0008"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Information and Investigational Drug Services, University of Michigan Hospitals, Ann Arbor 48109-0008","institution_ids":["https://openalex.org/I4210114445"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5048819113"],"corresponding_institution_ids":["https://openalex.org/I4210114445"],"apc_list":null,"apc_paid":null,"fwci":3.346,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.9235474,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"10","issue":"6","first_page":"447","last_page":"456"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.6068999767303467,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.6068999767303467,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.32739999890327454,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.05909999832510948,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":1.0},{"id":"https://openalex.org/keywords/memory-loss","display_name":"memory loss","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cholinergic-hypothesis","display_name":"cholinergic hypothesis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/physostigmine","display_name":"physostigmine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cholinomimetic-agents","display_name":"cholinomimetic agents","score":0.7749999761581421},{"id":"https://openalex.org/keywords/arecoline","display_name":"arecoline","score":0.8009999990463257},{"id":"https://openalex.org/keywords/neurofibrillary-tangles","display_name":"neurofibrillary tangles","score":0.7850000262260437},{"id":"https://openalex.org/keywords/neuritic-plaques","display_name":"neuritic plaques","score":0.968999981880188},{"id":"https://openalex.org/keywords/cortical-atrophy","display_name":"cortical atrophy","score":0.7429999709129333},{"id":"https://openalex.org/keywords/neurotransmitter-deficiency","display_name":"neurotransmitter deficiency","score":0.460999995470047},{"id":"https://openalex.org/keywords/lecithin","display_name":"lecithin","score":0.7590000033378601},{"id":"https://openalex.org/keywords/choline","display_name":"choline","score":0.8169999718666077},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.8182401657104492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.691053032875061},{"id":"https://openalex.org/C2776663719","wikidata":"https://www.wikidata.org/wiki/Q410595","display_name":"Physostigmine","level":3,"score":0.6700056791305542},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.6407710909843445},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.5709441900253296},{"id":"https://openalex.org/C198399640","wikidata":"https://www.wikidata.org/wiki/Q14863671","display_name":"Choline acetyltransferase","level":3,"score":0.5678387880325317},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.534255862236023},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.5301094055175781},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.42869627475738525},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.4006921052932739},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.38590970635414124},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3562489151954651},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.35262274742126465},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3483697175979614},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.3007532060146332},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.15398311614990234},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07284584641456604},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008569","descriptor_name":"Memory Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008569","descriptor_name":"Memory Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D010713","descriptor_name":"Phosphatidylcholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2065522","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2065522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacy","raw_type":"Clinical Trial"},{"id":"mag:165383261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2065522","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W181642418","https://openalex.org/W2422339592","https://openalex.org/W4410118819","https://openalex.org/W2418360471","https://openalex.org/W2137777161","https://openalex.org/W1997451642","https://openalex.org/W2025611371","https://openalex.org/W2396571618","https://openalex.org/W2055984415","https://openalex.org/W2160371310"],"abstract_inverted_index":{"The":[0,30],"pathophysiology,":[1],"symptomatology,":[2],"and":[3,27,63,70,131,181],"treatment":[4],"of":[5,37,45,67,93,117,144],"memory":[6,69,76,210],"loss":[7,77,211],"in":[8,54,157,170,178,193,208],"patients":[9,55,82,158,194],"with":[10,56,159,164,195,213],"Alzheimer's":[11,15,57,94,160,196],"disease":[12,16,58,95],"are":[13,73,149],"described.":[14],"is":[17,78],"characterized":[18],"by":[19,113,125,136],"cerebral":[20],"cortical":[21],"atrophy,":[22],"neuronal":[23],"loss,":[24],"neurofibrillary":[25],"tangles,":[26],"neuritic":[28],"plaques.":[29],"primary":[31],"neuropharmacologic":[32],"defect":[33],"involves":[34],"reduced":[35,43],"activity":[36],"the":[38,84,115,183,191,209],"enzyme":[39],"choline":[40],"acetyltransferase,":[41],"causing":[42],"synthesis":[44],"acetylcholine":[46],"(ACh).":[47],"Other":[48],"neurotransmitters":[49],"known":[50],"to":[51,86,105,185],"be":[52,97],"compromised":[53],"include":[59,109],"norepinephrine,":[60],"serotonin,":[61],"dopamine,":[62],"somatostatin.":[64],"Initially":[65],"components":[66],"short-term":[68],"immediate":[71],"recall":[72],"lost.":[74],"Eventually,":[75],"so":[79],"severe":[80],"that":[81,204],"lose":[83],"ability":[85],"care":[87],"for":[88],"themselves.":[89],"A":[90],"definite":[91],"diagnosis":[92],"can":[96],"made":[98],"only":[99],"at":[100],"autopsy.":[101],"Three":[102],"pharmacologic":[103],"approaches":[104],"enhancing":[106],"cholinergic":[107,134],"function":[108],"increasing":[110,114],"ACh":[111,118,123],"production":[112],"availability":[116],"precursors":[119],"(lecithin,":[120],"choline);":[121],"inhibiting":[122,126],"degradation":[124],"acetylcholinesterase":[127],"(physostigmine,":[128],"tacrine":[129,165],"hydrochloride);":[130],"directly":[132],"stimulating":[133],"receptors":[135],"using":[137],"cholinomimetic":[138],"agents":[139,148],"(arecoline,":[140],"RS-86).":[141],"However,":[142],"results":[143],"studies":[145],"involving":[146],"these":[147],"conflicting:":[150],"no":[151,198],"consistent":[152,206],"benefit":[153],"has":[154,167,174,182,200],"been":[155,168,176,202],"shown":[156],"disease.":[161,215],"Although":[162],"therapy":[163],"hydrochloride":[166],"beneficial":[169],"some":[171],"patients,":[172],"it":[173],"not":[175],"effective":[177],"all":[179],"cases":[180],"potential":[184],"cause":[186],"serious":[187],"adverse":[188],"effects.":[189],"Despite":[190],"research":[192],"disease,":[197],"agent":[199],"yet":[201],"found":[203],"produces":[205],"improvement":[207],"associated":[212],"this":[214]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W165383261","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
